Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ABBV-CLS-579 |
Trade Name | |
Synonyms | ABBV-CLS579|ABBV-CLS 579|ABBV 579 |
Drug Descriptions |
ABBV-CLS-579 inhibits PTPN2 and PTPN1, which potentially leads to antitumor activity (Cancer Res (2023) 83 (8_Supplement): CT257). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ABBV-CLS-579 | ABBV-CLS-579 | 0 | 1 |
ABBV-CLS-579 + unspecified PD-1 antibody | ABBV-CLS-579 unspecified PD-1 antibody | 0 | 1 |